Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III open-label study of Begrivac preservative-free inactivated split influenza vaccine in healthy adults and elderly
2007-001403-38Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of Agrippal S1 in influenza (2 arms), sponsored by Novartis. Primary endpoints: Immunogenicity measures and Safety. Started Apr 2007; status: completed.
02
Drugs
Agrippal S1
03
Conditions
influenza
Beyond the preview
Go deeper on 2007-001403-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001403-38.